p14ARF, MDM2 and TP53 have been shown to present frequent mutations in many tumors [17–19]; However, to the best of our knowledge, no studies have addressed the role of genetic variants of the p14ARF/MDM2/TP53 signaling pathway in the prognosis of ESCC. The gene discussed is MDM2; the disease is esophageal squamous cell carcinoma.